ZB
TNDM icon

Zions Bancorporation’s Tandem Diabetes Care TNDM Stock Holding History

Zions Bancorporation’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-93
Closed -$3.75K – 926
2024
Q2 		$3.75K Buy
93
+8
+9% +$334 ﹤0.01% 785
2024
Q1 		$3.01K Sell
85
-2
-2% -$54 ﹤0.01% 807
2023
Q4 		$2.57K Sell
87
-51
-37% -$1.06K ﹤0.01% 806
2023
Q3 		$2.87K Hold
138
– – ﹤0.01% 786
2023
Q2 		$3.39K Sell
138
-13
-9% -$418 ﹤0.01% 776
2023
Q1 		$6.13K Sell
151
-88
-37% -$3.64K ﹤0.01% 715
2022
Q4 		$10.7K Sell
239
-6,515
-96% -$295K ﹤0.01% 691
2022
Q3 		$323K Buy
6,754
+12
+0.2% +$658 0.03% 263
2022
Q2 		$399K Buy
6,742
+1,412
+26% +$116K 0.04% 256
2022
Q1 		$620K Buy
5,330
+1,545
+41% +$180K 0.06% 218
2021
Q4 		$570K Buy
3,785
+662
+21% +$89.4K 0.05% 210
2021
Q3 		$373K Buy
+3,123
New +$344K 0.04% 239

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zions Bancorporation's TNDM Position: Q3 2024 in Review

Zions Bancorporation sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 93 shares — an estimated $3.75K sold.

Zions Bancorporation first reported a position in TNDM in Q3 2021 and held it in 12 quarters. The position peaked at $620K in Q1 2022. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Zions Bancorporation reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Zions Bancorporation sold 93 Tandem Diabetes Care shares in Q3 2024, an estimated $3.75K.
  • Zions Bancorporation first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 12 quarters.
  • Zions Bancorporation's Tandem Diabetes Care position peaked at $620K in Q1 2022.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Zions Bancorporation's 13F filing for Q3 2024, filed 6 Nov 2024.